Not Cleared Direct

DEN220042 - Terragene Bionova Photon Biological Indicator (BT225) (FDA 510(k) Clearance)

Also includes:
Terragene Bionova Photon Auto-Reader Incubator (BPH)
Jul 2024
Decision
742d
Days
Class 2
Risk

DEN220042 is an FDA 510(k) submission for the Terragene Bionova Photon Biological Indicator (BT225). This device is classified as a Biological Sterilization Indicator With Indirect Growth Detection (Class II - Special Controls, product code QVB).

Submitted by Terragene S.A. (Alvear, AR). The FDA issued a Not Cleared (DENG) decision on July 12, 2024.

This device falls under the General Hospital FDA review panel. Regulated under 21 CFR 880.2806. A Biological Sterilization Indicator With Indirect Growth Detection Capabilities Is A Device Intended For Use By A Healthcare Provider To Accompany Products Being Sterilized Through A Sterilization Process To Monitor The Adequacy Of Sterilization. Detection Of Surviving Microorganisms Is Accomplished By A Method Other Than Direct Detection Of Growth Or Growth Products..

Submission Details

510(k) Number DEN220042 FDA.gov
FDA Decision Not Cleared Not Substantially Equivalent (DENG)
Date Received July 01, 2022
Decision Date July 12, 2024
Days to Decision 742 days
Submission Type Direct
Review Panel General Hospital (HO)
Summary -

Device Classification

Product Code QVB - Biological Sterilization Indicator With Indirect Growth Detection
Device Class Class II - Special Controls
CFR Regulation 21 CFR 880.2806
Definition A Biological Sterilization Indicator With Indirect Growth Detection Capabilities Is A Device Intended For Use By A Healthcare Provider To Accompany Products Being Sterilized Through A Sterilization Process To Monitor The Adequacy Of Sterilization. Detection Of Surviving Microorganisms Is Accomplished By A Method Other Than Direct Detection Of Growth Or Growth Products.